The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN), a global, clinical-stage biotechnology company developing and manufacturing novel therapies, announced today the submission ...

HANGZHOU, China--(BUSINESS WIRE)--Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to cell ...

Microalgae biotechnology has emerged as a dynamic field that exploits these photosynthetic microorganisms for a wide range of sustainable applications. Owing to their rapid growth, high lipid content ...

PITTSBURGH, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development, and ...

PITTSBURGH, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercialization ...

BEIJING, Nov. 15, 2021 /PRNewswire/ -- HebaBiz Biotech is pleased to announce that in November 2021, the Center for Drug Evaluation (CDE) of The National Medical Products Administration (NMPA) of ...

Magnetic bead separation is a fast, effective, and clean process that scientists use as an alternative to filtration and centrifugation techniques for separation. Magnetic beads and particles can be ...

GlaxoSmithKline (GSK) today announced the submission of a new drug application to the US Food and Drug Administration and new data from two Phase III trials for Rezonic TM /Zunrisa TM (casopitant), a ...

Cyanophycin is a versatile nitrogen storage polymer naturally synthesised by many bacteria. Composed of a poly-L-aspartate backbone with covalently attached L-arginine residues, this biopolymer ...

Krystal Biotech (KRYS) announced that the United States Food and Drug Administration, FDA, approved a label update for VYJUVEK that expands the ...

BLA submission to the U.S. FDA follows successful conclusion of Evive’s Global Phase III Clinical Trial for chemotherapy-induced neutropenia in breast cancer patients. Evive is the first Chinese ...